Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

UTIs are among the most common infections worldwide, affecting some 15 million women a year. Phenazopyridine, sold under brand names such as Azo and Uristat, is used to treat the pain, burning and ...

The menopause transition is often accompanied by a wide array of symptoms, some of which receive more attention than others.

Learn how to prevent urinary tract infections (UTIs) with simple daily habits. Discover hygiene tips, hydration advice, diet ...

Shares of Spero Therapeutics SPRO more than tripled in market value yesterday after a phase III study evaluating its ...

GSK and Spero Therapeutics’ Phase III trial of their oral antibiotic for complicated urinary tract infections (cUTI) will end ...

A COMMON over-the counter medication that’s been available for decades and is taken by millions worldwide has been singled out for its possible cancer risk. Phenazopyridine, typically sold ...

A common over-the counter medication that’s been available for decades and is taken by millions worldwide has been singled out for its possible cancer risk.

Shares of Spero Therapeutics gained after the company and GSK ended their trial for a treatment for complicated urinary tract infections early after it met its primary endpoint. The stock more than ...

Popular over-the-counter drugs used to treat uncomfortable urinary tract infections may come with a potential cancer risk.

Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...